Paediatric Vaccinations


The ideal measure of efficacy, infection rates, is usually not studied as a primary endpoint because this requires large sample sizes. Surrogate measures such as immunogenicity are commonly used instead. Immunogenicity refers to the immune response induced by vaccination. Increased disease activity induced by vaccination and unintentional infections induced by live-attenuated pathogens in vaccines (especially in patients on high-dose immunosuppressive drugs). Another issue of vaccine safety is whether vaccines or their constituents can actually cause autoimmune disease (AID), which will be addressed briefly.



 


  • Two doses of measles mumps rubella at 9 and 15 months of age, and no standalone measles vaccine at 9 months.
  • Single dose administration of live attenuated H2 strain hepatitis A vaccine, or two doses of inactivated (killed) hepatitis A vaccine.

Related Conference of Paediatric Vaccinations

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
March 24-24, 2021

3rd International Conference on Dermatology and Allergic Diseases

Singapore City, Singapore
April 15-16, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
April 19-20, 2021

9th World Summit on immunology & immunotherapy

Prague, Czech Republic
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

Paediatric Vaccinations Conference Speakers

Recommended Sessions

Related Journals

Are you interested in